ADHD UPDATE
WARNING! Boring technical post ahead.
I’m not quite sure what to make of this. McNeil Consumer & Specialty Pharmaceuticals, maker of ADHD-drug Concerta, has requested the DEA to reduce Concerta’s classification from Schedule II to Schedule III. Ritalin, which contains the exact same AI as Concerta, would remain on Schedule II.